For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Contract manufacturing is the process where manufacturer engages into an agreement with the companies for component or product manufacturing. Active pharmaceutical ingredient (API) contract manufacturing refers to the development of pharmaceutical drugs through contract manufacturing by outsourcing to other companies.
Scope of the Report:
The global API Contract Manufacturing market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of API Contract Manufacturing.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the API Contract Manufacturing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the API Contract Manufacturing market by product type and applications/end industries.
Market Segment by Companies, this report covers
- AstraZeneca Plc
- BoehringerIngelhein GmbH
- GlaxoSmithKline Pharmaceuticals Ltd
- Merck&Co.,Inc
- Novartis AG
- Piramal Pharma Solutions
- Ranbaxy Laboratories Ltd.
- Reddy's Laboratories Ltd
- Sandoz-Lek-Biochemie
- Sun Pharmaceutical Industries Ltd
- Teva Pharmaceuticals Industries Ltd
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Commercial Manufacturing
- Clinical Manufacturing
Market Segment by Applications, can be divided into
- Oncology
- Central nervous system
- Cardiovascular disorder
- Infectious diseases
- Pulmonary disorders
- Metabolic disorder
- Gastrointestinal disorders
- Musculoskeletal disorders
- Genitourinary disorders